Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Lipid Metabolism Disorders » Dyslipidemias
Description
Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL. MeSH
Hierarchy View
Subtype Terms (3)
Hyperlipidemias
206 drugs (81 approved, 125 experimental)
Hypolipoproteinemias
2 approved drugs
Smith-Lemli-Opitz Syndrome
6 drugs (3 approved, 3 experimental)
Phase 4 Indicated Drugs (39)
Phase 3 Indicated Drugs (43)
Phase 2 Indicated Drugs (43)
Other Experimental Indicated Drugs (86)
Organization Involved with Phase 4 Indications (90)
All India Institute of Medical Sciences
Bangabandhu Sheikh Mujib Medical University
China Academy of Chinese Medical Sciences
Daewon Pharmaceutical Co., Ltd.
Daewoong Pharmaceutical Co. LTD.
Foundation for Cardiovascular Research, Zurich
Genovate Biotechnology Co., Ltd.,
Hospital Italiano de Buenos Aires
Hospital Santa Marcelina, Sao Paulo, Brasil
Hospital Universitari de Bellvitge
In His Image Family Medicine Residency
National Center for Complementary and Integrative Health (NCCIH)
National Heart, Lung, and Blood Institute (NHLBI)
Pontificia Universidad Catolica de Chile
Rundo International Pharmaceutical Research & Development Co.,Ltd.
Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders
Taichung Veterans General Hospital
Organization Involved with Phase 3 Indications (55)
Ache Laboratorios Farmaceuticos S.A.
Bonn Education Association for Dietetics r.A., Cologne, Germany
Boryung Pharmaceutical Company
Diabetes and Glandular Disease Research Associates Inc.
Organization Involved with Phase 2 Indications (56)
Medical Affiliated Research Center, Inc.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Romania:The National Authority for Scientific Research
South Australian Health and Medical Research Institute
Organization Involved with Phase 1 Indications (24)
Organization Involved with Other Experimental Indications (67)
Agroscope Liebefeld-Posieux Research Station ALP
Baqiyatallah Medical Sciences University
California Strawberry Commission
Centre de Recherche en Nutrition Humaine Rhone-Alpe
Chinese Academy of Medical Sciences
Clinical Research Institute HUCH Ltd
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Institut National de la Santé Et de la Recherche Médicale, France
Instituto Nacional de Cardiologia de Laranjeiras
Institut Polytechnique LaSalle Beauvais
Medical University of South Carolina
National Institute of Allergy and Infectious Diseases (NIAID)
Rio de Janeiro State University
Shaheed Zulfiqar Ali Bhutto Medical University
Silesian University of Medicine
The Regional Centre for Studies in Food and Health (CREAS), Valparaíso, Chile
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
